June 25, 2024
5 min watch
Save
VIDEO: Treatment delays do not lead to acute myeloid leukemia survival disparities
In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting researching inequities in acute myeloid leukemia treatment in historically marginalized communities.
Hantel, a medical oncologist at Dana-Farber Cancer Institute, highlighted the study, which found that in some subsets of patients a delay in the beginning of treatment did not necessarily correlate to lower survival outcomes.
“If anything, the study was kind of reassuring in that despite any differences in access to timely treatment by race and ethnicity, there weren't disparities in survival because of that.,” Hantel said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Hantel reports no relevant financial disclosures.
Read more about